Trinity Biotech Announces The Successful Closing of its Debt Refinancing
DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic...
Month: January 2022
Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today...
Applied Molecular Transport Announces Board Appointments
John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair...
Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
CooperCompanies Announces Release Date for First Quarter 2022
SAN RAMON, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release first quarter 2022...
Vaccinex Announces $6.6 Million Private Placement
Participants include a syndicate of existing and new shareholdersContributes to total of $10.1 million in new equity financing for January,...
Stryker reports 2021 operating results and 2022 outlook
Kalamazoo, Michigan, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year...
23andMe to Report FY2022 Third Quarter Financial Results
SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5%Note: A webcast of ResMed’s conference call will...
NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference
MOUNTAIN VIEW, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on...
VitalHub Corp. Announces Acquisition of Beautiful Information
TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (the “Company” or “VitalHub”) is pleased to announce today...
Freeline to Present on Its Fabry and Gaucher Disease AAV-Based Gene Therapies at the 18th Annual WORLDSymposium™
LONDON, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology...
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update
Advanced four wholly owned and internally developed programs into clinical development Strengthened balance sheet with year-end cash and investments totaling...
LifeLabs’ President and CEO receives ‘Top Industry Leader’ award
Life Sciences Voice (LSV) is the leading resource for life sciences executives to get crucial insights, explore the latest innovations,...
National Research Corporation to Broadcast its 2021 Fourth Quarter Conference Call Live on the Internet
Lincoln, Nebraska, Jan. 27, 2022 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online...
Quipt Home Medical Announces Date and Time for Q4 and Full Year Fiscal 2021 Conference Call and Audio Webcast
CINCINNATI, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSXV: QIPT), a U.S. based...
Ocugen, Inc. Signs Letter of Intent to Acquire Vaccine Manufacturing, R&D Hub in Ontario, Canada
Dormant Vaccine Manufacturing site currently owned by an affiliate of Liminal BioSciences intended to bring new capabilities to Ocugen’s medicine...
Fuwai Central China Cardiovascular Hospital Becomes First to Offer Advanced Robotic Treatment for Heart Rhythm Disorders in Central China
ST. LOUIS, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program
Toronto, Ontario--(Newsfile Corp. - January 28, 2022) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red...
Sparta Provides Status Report on Delay in Filing Annual Financial Statements
Not for distribution to U.S. Newswire Services or for dissemination in the United States of America.Any failure to comply with...